Given the activity of PAHs in inducing CYP2E1, smokers taking INH as part of TB therapy may experience increased synthesis of reactive intermediates resulting from further oxidation of oxidised HZ and AcHZ. This evidence concerns the gene CYP2E1 and tuberculosis.